Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endothelialized ePTFE Graft by Nanobiotechnology

NCT02002104 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT02002104
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02002104 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endothelialized ePTFE Graft by Nanobiotechnology
Lead sponsor
National Taiwan University Hospital
Phase
Observational
Overall status
Completed
Start date
September 30, 2010
Completion date
June 30, 2011
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

the apparatus for processing the tubular graft modification will be designed and evaluated., the on-site capturing of the endothelial (progenitor) cells by peptide-mediated selective adhesion in vitro and in vivo will also be elucidated., the patency rate of itri-made artificial blood vessels will be evaluated by the porcine animal model.